Optical coherence tomography (OCT) is widely used for retinal imaging in ophthalmology clinics around the world. Considering that OCT was introduced a mere 33 years ago,
1 the fact that OCT is now used in millions of procedures each year presents a spectacular example of the translation of biomedical optics technology from the research bench to the clinic.
2 However, there are still several use cases for OCT that have not been fully realized due to the cost, size, and weight of current OCT systems. Clinical OCT systems are feature rich and can cost up to $150,000. The size of an OCT system may be up to 1 m
3, and it may weigh as much as 30 kg. These attributes place constraints on access to this imaging modality outside of large eye clinics and hospitals.
3 Recent research on low-cost and portable systems has begun to tap into the potential of using OCT in new settings.
Our group introduced a low-cost spectral-domain OCT (SD-OCT) system in 2018 which used three-dimensional (3D) printing to reduce the complexity and cost of the spectrometer design.
4 This system cost approximately $7000, weighed 2.7 kg, and relied on multiple developer kits to acquire and process spectral data into OCT images. We further refined this system for clinical study by utilizing custom microcontrollers on customized circuit boards. The clinical low-cost OCT system located the light source and interferometer via a handheld scanner.
5 The resulting system was highly compact at 4096 cm
3, lightweight at just 2.3 kg, and low cost with a bill of materials of $5000. The performance of the clinical low-cost OCT system was benchmarked against a commercially available clinical OCT system, the SPECTRALIS (Heidelberg Engineering, Heidelberg, Germany). Although the SPECTRALIS was found to offer superior imaging performance, the dramatic differences in cost, size, and weight suggested a potential role for a clinical low-cost OCT system. Lumedica (Durham, NC) has commercialized low-cost OCT based on these designs. Philophos (Daejeon, South Korea) has also introduced a compact, low-cost OCT device. Recently, a prototype compact, low-cost OCT was introduced for horticultural research.
6 The cost and size of this system are comparable to the above-listed systems at 5647 cm
3 and cost of €6200; however, the relatively low A-scan rate of 7.4 kHz is likely only suitable for imaging static samples.
There have been other approaches for increasing access to OCT imaging technology. Handheld OCT devices were developed to image supine patients and found application to imaging neonates.
7,8 These devices focused on a small handheld probe, typically attached to a full-size OCT system. On the other hand, some efforts have sought to miniaturize the components used in OCT. A recent review of miniaturizing OCT detailed current progress on developing photonic integrated circuits (PICs) for this purpose.
9 This approach is compelling, as the potential to integrate an entire OCT system into a monolithic element could result in highly compact and cost-effective systems. A recent approach for OCT is to enable self-examination with home-based devices,
10–12 including a full-field OCT imaging device based on a time-domain approach and a commercial device from Notal Vision (Manassas, VA), which was recently authorized for use by the U.S. Food and Drug Administration.
Here, we report on an advance that will increase access to OCT by enabling higher performance in low-cost systems. Rather than use a full-featured personal computer (PC) for acquiring and processing data, the computing power of the Jetson Orin Nano (NVIDIA, Santa Clara, CA) is used. Operating software has been converted from Windows to Linux and reconfigured to leverage the highly parallel processing capabilities of the Jetson. A fivefold increase in processing is realized while a reduction in cost and size is also achieved, resulting in the highest performance seen in a low-cost system to date. System performance is described here and benchmarked for retinal imaging.